Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.
Bersanelli M, Verzoni E, Cortellini A, Giusti R, Calvetti L, Ermacora P, Di Napoli M, Catino A, Guadalupi V, Guaitoli G, Scotti V, Mazzoni F, Veccia A, Guglielmini PF, Perrone F, Maruzzo M, Rossi E, Casadei C, Montesarchio V, Grossi F, Rizzo M, Travagliato Liboria MG, Mencoboni M, Zustovich F, Fratino L, Accettura C, Cinieri S, Camerini A, Sorarù M, Zucali PA, Ricciardi S, Russo A, Negrini G, Banzi MC, Lacidogna G, Fornarini G, Laera L, Mucciarini C, Santoni M, Mosillo C, Bonetti A, Longo L, Sartori D, Baldini E, Guida M, Iannopollo M, Bordonaro R, Morelli MF, Tagliaferri P, Spada M, Ceribelli A, Silva RR, Nolè F, Beretta G, Giovanis P, Santini D, Luzi Fedeli S, Nanni O, Maiello E, Labianca R, Pinto C, Clemente A, Tognetto M, De Giorgi U, Pignata S, Di Maio M, Buti S, Giannarelli D; FICOG group (Federation of Italian Cooperative Oncology Groups). Bersanelli M, et al. Among authors: morelli mf. EClinicalMedicine. 2023 Jun 29;61:102044. doi: 10.1016/j.eclinm.2023.102044. eCollection 2023 Jul. EClinicalMedicine. 2023. PMID: 37434748 Free PMC article.
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study.
Del Vecchio M, Chiarion Sileni V, Quaglino P, Rinaldi G, Minisini A, Troiani T, Consoli F, Sponghini A, Banzi M, Morelli MF, Palleschi D, Rossi E, Marconcini R, Depenni R, Carnevale-Schianca F, Marcon I, Queirolo P. Del Vecchio M, et al. Among authors: morelli mf. Cancers (Basel). 2023 Mar 26;15(7):1980. doi: 10.3390/cancers15071980. Cancers (Basel). 2023. PMID: 37046641 Free PMC article.
Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program.
Quaglino P, Ascierto PA, Consoli F, Queirolo P, Spagnolo F, Morelli MF, Berardi R, Chiarion-Sileni V, Tucci M, Troiani T, Melotti B, Rossi E, Mandala M, Rinaldi G, Marcon IG, Pizzuti M, Del Vecchio M. Quaglino P, et al. Among authors: morelli mf. Cancer Manag Res. 2023 Nov 11;15:1271-1281. doi: 10.2147/CMAR.S423970. eCollection 2023. Cancer Manag Res. 2023. PMID: 38027240 Free PMC article.
Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study.
Verkhovskaia S, Falcone R, Di Pietro FR, Carbone ML, Samela T, Perez M, Poti G, Morelli MF, Zappalà AR, Di Rocco ZC, Morese R, Piesco G, Chesi P, Marchetti P, Abeni D, Failla CM, De Galitiis F. Verkhovskaia S, et al. Among authors: morelli mf. Cancers (Basel). 2024 Oct 4;16(19):3397. doi: 10.3390/cancers16193397. Cancers (Basel). 2024. PMID: 39410017 Free PMC article.
Retrospective-Prospective Observational Study of Italian Patients Treated in Melanoma Adjuvant Cohort MAP-MADAM (Maximing ADjuvAnt MAP): Interim Analysis.
Consoli F, Tucci M, Pigozzo J, Simeone E, Spagnolo F, Troiani T, Morgese F, Del Vecchio M, Melotti B, Tronconi MC, Morelli MF, Grosso F, Merelli B, Marcon I, Valsecchi D, Quaglino P. Consoli F, et al. Among authors: morelli mf. Cancers (Basel). 2024 Dec 5;16(23):4072. doi: 10.3390/cancers16234072. Cancers (Basel). 2024. PMID: 39682258 Free PMC article.
Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients.
Di Pietro FR, Verkhovskaia S, Falcone R, Poti G, Carbone ML, Morelli MF, Zappalà AR, Morese R, Di Rocco ZC, Piesco G, Chesi P, Failla CM, Marchetti P, De Galitiis F. Di Pietro FR, et al. Among authors: morelli mf. Front Oncol. 2024 Aug 1;14:1437325. doi: 10.3389/fonc.2024.1437325. eCollection 2024. Front Oncol. 2024. PMID: 39148899 Free PMC article.
Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center.
Falcone R, Verkhovskaia S, Di Pietro FR, Poti G, Samela T, Carbone ML, Morelli MF, Zappalà AR, di Rocco ZC, Morese R, Piesco G, Marchetti P, Failla CM, De Galitiis F. Falcone R, et al. Among authors: morelli mf. Curr Oncol. 2024 Jan 22;31(1):588-597. doi: 10.3390/curroncol31010042. Curr Oncol. 2024. PMID: 38275835 Free PMC article.
Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience.
Di Pietro FR, Marinelli D, Verkhovskaia S, Poti G, Falcone R, Carbone ML, Morelli MF, Zappalà AR, Di Rocco ZC, Morese R, Piesco G, Chesi P, Marchetti P, Failla CM, De Galitiis F. Di Pietro FR, et al. Among authors: morelli mf. BMC Cancer. 2024 Oct 1;24(1):1220. doi: 10.1186/s12885-024-12961-9. BMC Cancer. 2024. PMID: 39354418 Free PMC article.
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study.
Morelli MF, Santomaggio A, Ricevuto E, Cannita K, De Galitiis F, Tudini M, Bruera G, Mancini M, Pelliccione M, Calista F, Guglielmi F, Martella F, Lanfiuti Baldi P, Porzio G, Russo A, Gebbia N, Iacobelli S, Marchetti P, Ficorella C. Morelli MF, et al. Oncol Rep. 2010 Jun;23(6):1635-40. doi: 10.3892/or_00000805. Oncol Rep. 2010. PMID: 20428819 Free article. Clinical Trial.
Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancer.
Rispoli AI, Morelli MF, Ricevuto E, Cannita K, Santomaggio A, Mancini M, Tudini M, Cianci G, Porzio G, Lanfiuti Baldi P, Di Rocco CZ, Tinari N, Iacobelli S, Marchetti P, Ficorella C. Rispoli AI, et al. Among authors: morelli mf. Breast J. 2008 Jan-Feb;14(1):116-7. doi: 10.1111/j.1524-4741.2007.00540.x. Epub 2007 Dec 13. Breast J. 2008. PMID: 18086273 Clinical Trial. No abstract available.
17 results